Get the Stockscreener App
1.725
7.26%
-0.135
After Hours:
1.80
0.075
+4.35%
Cdt Equity Inc stock is traded at $1.725, with a volume of 29,085.
It is down -7.26% in the last 24 hours and down -63.06% over the past month.
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
See More
Previous Close:
$1.86
Open:
$1.88
24h Volume:
29,085
Relative Volume:
0.39
Market Cap:
$8.38M
Revenue:
-
Net Income/Loss:
$-39.62M
P/E Ratio:
-0.00104
EPS:
-1654.3275
Net Cash Flow:
$-17.96M
1W Performance:
-13.97%
1M Performance:
-63.06%
6M Performance:
-96.91%
1Y Performance:
-99.86%
1-Day Range:
$1.6912
$1.9334
1-Week Range:
$1.6912
$2.1896
52-Week Range:
$1.6912
$1,216.80
Cdt Equity Inc Stock (CDT) Company Profile
Name
Cdt Equity Inc
Sector
Industry
Phone
(646) 491 9132
Address
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
1.725 | 9.04M | 0 | -39.62M | -17.96M | -1,654.33 |
VRTX
Vertex Pharmaceuticals Inc
|
436.95 | 114.32B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
698.25 | 74.74B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
799.32 | 51.13B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
286.98 | 39.18B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
145.66 | 31.78B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cdt Equity Inc Stock (CDT) Latest News
CDT Equity Flags Delay in Quarterly Filing - TipRanks
CDT Equity Modifies Financing Agreements to Boost Liquidity - TipRanks
CDT Equity (NASDAQ: CDT) notifies SEC of delayed Q1 2026 10-Q; plans filing - Stock Titan
Cdt Equity Inc enters amendment no. 2 to equity line of credit facility on May 15, 2026SEC filing - marketscreener.com
CDT Equity Inc. (NASDAQ: CDT) tweaks equity line and note proceeds - Stock Titan
Corvus updates CDT Equity (CDT) ownership to about a 5.4% stake - Stock Titan
CEO-linked entities of CDT Equity (CDT) add shares, exercise warrants - Stock Titan
Number of shareholders of CDT Equity Inc. – NASDAQ:CDT - TradingView
CDT Equity Advances AstraZeneca PLC (AZN)’s AZD5904 Into PCT Patent Protection Stage - Yahoo Finance
CDT Stock Price, Quote & Chart | CDT EQUITY INC (NASDAQ:CDT) - ChartMill
CDT Equity Inc shares plunge 7.96% as Q1 2026 shows zero revenue and massive loss.Direct Listing - newser.com
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market - The Manila Times
A patent filed in under 3 weeks puts CDT's Sarborg stake in focus - Stock Titan
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions - AI Magazine
After 181-subject safety studies, CDT seeks partner for infertility drug - Stock Titan
CDT Equity Inc. Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions - marketscreener.com
[EFFECT] CDT Equity Inc. SEC Filing - Stock Titan
5.35M CDT Equity (NASDAQ: CDT) shares registered for resale by selling holders - Stock Titan
CDT Equity (CDT) director discloses 233,585 Common Stock shares on Form 3 - Stock Titan
CDTTW (CDT Warrant) leadership outlines long-term growth priorities as latest quarterly earnings figures remain undisclosed.Recovery Report - newser.com
CDT Equity Announces Board Changes and New Chairperson - The Globe and Mail
CDT Equity announces reverse stock split - MSN
Board reshuffle at CDT Equity (NASDAQ: CDT) adds Ulrik Olsen, new chairs - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Conduit to change name to CDT Equity - MSN
Stock List: Research Stocks from Around the World - GuruFocus
Working capital per share of CDT Equity Inc. – FWB:ZK7 - TradingView
EBITDA per share of CDT Equity Inc. – FWB:ZK7 - TradingView
CDT Equityfiles for offering of up to 5.35 million shares of common stockSEC filing - marketscreener.com
CDT Equity (NASDAQ: CDT) registers 5.35M shares; ELOC and Sarborg issuances - Stock Titan
Equity Inc (CDT) Stock: Is It Reasonably Valued (Dips) 2026-04-20Elite Trading Signals - Xã Thanh Hà
CDT Notes Sarborg Publication of PRISM Framework Expanding AI - 富途牛牛
Prospect Capital Securities Ltd Net Worth (2026) - GuruFocus
Prospect Finance Ltd Net Worth (2026) - GuruFocus
Mark Andrew Taylor Net Worth (2026) - GuruFocus
Keep an eye on the top gainers and losers in Thursday's session. - ChartMill
AstraZeneca (AZN) Advances Portfolio with Strategic Update - GuruFocus
CDT Equity expands multi-pathway value creation strategy across pharma, IP - TipRanks
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery - The Manila Times
Tiny Nasdaq biotech links AstraZeneca assets with AI drug hunting - Stock Titan
CDT Equity Inc. 2025 Annual Report: Nasdaq Listing, Reverse Stock Splits, and Financial Highlights (CDT, CDTTW) - Minichart
CDT Equity Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
AI-focused CDT Equity (Nasdaq: CDT) warns of going concern risk - Stock Titan
What's Going On With CDT Equity Shares On Monday? - Sahm
CDT Equity Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Which stocks are experiencing notable movement on Friday? - ChartMill
Cdt Equity Inc Stock (CDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):